Trusted by:
Decades of research leads to self-contained solar panels that convert CO2 into C2 products, valuable precursory chemicals of innumerable products in our everyday lives, from plastic polymers to jet fuel.
A groundbreaking new study published in Nature yesterday sheds light on the alarming rise of colorectal cancer in younger adults. Researchers sequenced the DNA of colorectal cancer tumors from 981 patients across 11 countries and discovered a significant link between colibactin-producing bacteria and early-onset disease.
Researchers have developed a drone system that uses blockchain sharding to significantly enhance the speed, security, and real-time coordination of search and rescue missions.
Switchgrass has gripped Midwestern soils for millions of years, but soon, the earthbound prairie grass could fly. New studies from the University of Illinois Urbana-Champaign identify economic and environmental considerations that make switchgrass a candidate for sustainable aviation fuel.
Researchers with UC San Diego Health identify a potential new treatment for uncontrolled high blood pressure.
An artificial intelligence (AI)-based model developed by UT Southwestern Medical Center researchers can accurately predict which kidney cancer patients will benefit from anti-angiogenic therapy, a class of treatments that鈥檚 only effective in some cases. Their findings, published in Nature Communications, could lead to viable ways to use AI to guide treatment decisions for this and other types of cancer.
A new algorithm has been developed to simultaneously estimate multiple shortwave radiation components using data from China's Fengyun-3F satellite.
Mayo Clinic researchers have identified a potential new way to monitor the progression of high-grade gliomas, one of the most aggressive types of brain cancer. Their feasibility study suggests that a personalized blood test tailored to each patient's tumor DNA could provide a faster and less invasive way to determine if the cancer is advancing.
In a recent paper, published in Nature, researchers from the University of Michigan have discovered that simultaneously targeting PIKfyve and KRAS-MAPK can eliminate tumors in preclinical human and mouse models.
In a landmark clinical trial, coordinated by the Alzheimer's Disease Cooperative Study at UC San Diego, people at risk for Alzheimer's who exercised at low or moderate-high intensity showed less cognitive decline when compared to those receiving usual care.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal 麻豆传媒 keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
